State of New Jersey Common Pension Fund A’s Acceleron Pharma XLRN Stock Holding History

State of New Jersey Common Pension Fund A’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	$621K	Sell	18,000 -25,000	-58%	-$1.13M	﹤0.01%	775
2013 Q4	$1.7M	Buy	+43,000	New	+$1.04M	0.01%	689

Other funds holding XLRN

PVMCI

Polaris Venture Management Co IV Boston, Massachusetts $62.4M AUM 33.04% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

DVC

Deer VII & Co Larchmont, New York $317M AUM 30.89% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State of New Jersey Common Pension Fund A's XLRN Position: Q1 2014 in Review

State of New Jersey Common Pension Fund A reduced its Acceleron Pharma (XLRN) stake by 58% in Q1 2014, selling an estimated $1.13M and leaving 18,000 shares worth $621K. The position accounts for ﹤0.01% of the portfolio, ranked #775.

State of New Jersey Common Pension Fund A first reported a position in XLRN in Q4 2013 and has held it in 2 quarters since. The position peaked at $1.7M in Q4 2013. 79 funds tracked by Wall St. Rank hold XLRN as of Q1 2014.

State of New Jersey Common Pension Fund A held 18,000 shares of Acceleron Pharma worth $621K as of Q1 2014.
State of New Jersey Common Pension Fund A sold 25,000 Acceleron Pharma shares in Q1 2014, an estimated $1.13M.
Acceleron Pharma made up ﹤0.01% of State of New Jersey Common Pension Fund A's portfolio in Q1 2014, its #775 holding.
State of New Jersey Common Pension Fund A first reported a position in Acceleron Pharma in Q4 2013 and has held it in 2 quarters since.
State of New Jersey Common Pension Fund A's Acceleron Pharma position peaked at $1.7M in Q4 2013.
79 funds tracked by Wall St. Rank held Acceleron Pharma as of Q1 2014.

Based on State of New Jersey Common Pension Fund A's 13F filing for Q1 2014, filed 5 May 2014.